Clinical Trials List
2024-07-01 - 2027-11-30
Phase II
Recruiting4
ICD-10K51.90
Ulcerative colitis, unspecified, without complications
ICD-10K51.911
Ulcerative colitis, unspecified with rectal bleeding
ICD-10K51.912
Ulcerative colitis, unspecified with intestinal obstruction
ICD-10K51.913
Ulcerative colitis, unspecified with fistula
ICD-10K51.914
Ulcerative colitis, unspecified with abscess
ICD-10K51.918
Ulcerative colitis, unspecified with other complication
ICD-10K51.919
Ulcerative colitis, unspecified with unspecified complications
ICD-9556.9
Ulcerative colitis, unspecified
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Huey-Ling Chen 無
- 翁孟慈 無
- YEN-HSUAN NI 無
- 謝銘鈞 無
- 吳嘉峯 無
- CHIEN-CHIH TUNG 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Puo-Hsien Le 無
- 許振銘 無
- Cheng-Tang Chiu 無
- Cheng-Yu Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃柏儒 無
- Chun-Lung Feng 無
- 吳宜樺 無
- Tsung-Yu Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
200 participants
